10/6/2026
DemeRx appoints ibogaine expert Juan Sanchez-Ramos
Sanchez-Ramos joins as DemeRx advances its alcohol use disorder program.
Topic archive
drug development
3 stories
9/10/2026
FDA outlines new psychedelic drug framework in NEJM
The FDA highlights its evolving approach to psychedelic therapies amid a mental health crisis.
8/18/2026
Executive order aims to speed up medical treatments
April order seeks to fast-track therapies for serious conditions.